A growing number of Kenyan children are being diagnosed with Type 1 diabetes, driving up insulin demand and placing a heavy financial burden on families, according to local pharmacies. With insulin prices ranging from Sh800 to over Sh2,000 per vial, many families struggle to afford the daily doses critical to keeping their children alive.
Pharmacies across Kenya have reported a significant increase in insulin sales, reflecting the rising prevalence of Type 1 diabetes, an autoimmune condition requiring lifelong insulin therapy. “We’ve seen a steady rise in demand for insulin over the past few years, especially for pediatric patients,” said Dr. Jane Wambui, a pharmacist at a Nairobi-based chemist, who noted that prices vary widely depending on brand and availability. “A vial costing Sh800 to Sh2,000 may last only a few weeks, and families often need multiple vials monthly, alongside syringes and glucose monitors.”
The financial strain is compounded by Kenya’s healthcare system challenges, including inconsistent insulin supplies in public hospitals. Many families rely on private pharmacies, as the National Hospital Insurance Fund (NHIF) does not always cover the full cost of insulin or related supplies. “For low-income families, it’s a choice between insulin and basic needs like food,” said Mary Otieno, a mother of a 10-year-old with Type 1 diabetes, in an interview with local health advocates.
The Kenya Diabetes Management and Information Centre (DMI) has highlighted efforts to address the crisis, including partnerships with global organizations like the International Diabetes Federation’s Life for a Child program, which provides insulin to children in need. However, coverage remains limited. “We’re working to expand access, but the demand is overwhelming,” said Dr. Nancy Ngugi, a DMI spokesperson, emphasizing the need for subsidized insulin and better diabetes education.
Experts suggest that local insulin production and stronger government subsidies could alleviate the crisis. “Investing in local manufacturing and streamlining supply chains is critical to making insulin affordable,” said Dr. David Ameyo, an endocrinologist based in Nairobi.
As cases continue to rise, families and advocates are calling for urgent action to ensure affordable access to life-saving insulin for Kenya’s children.
